Original Literature | Model OverView |
---|---|
Publication
Title
Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signalingpathways.
Affiliation
Department of Medicine, School of Medicine, University of Pennsylvania,Philadelphia, PA, USA.
Abstract
Macrophages are major targets for infection by human immunodeficiency virus type1 (HIV-1). In addition to their role as productive viral reservoirs,inappropriate activation of infected and uninfected macrophages appears tocontribute to pathogenesis. HIV-1 infection requires initial interactionsbetween the viral envelope surface glycoprotein gp120, the cell-surface proteinCD4, and a chemokine receptor CCR5 or CXCR4. Besides their role in HIV-1 entry,CCR5 and CXCR4 are G protein-coupled receptors that can activate multipleintracellular signaling pathways. HIV-1 gp120 has been shown to activatesignaling pathways through the chemokine receptors in several cell typesincluding lymphocytes, neurons, and astrocytes. In some cell types, theseconsequences may cause cellular injury. In this review, we highlight our datademonstrating diverse signaling events that occur in primary human macrophagesin response to gp120/chemokine receptor interactions. These responses includeK+, Cl-, and nonselective cation currents, intracellular Ca2+ increases, andactivation of several kinases including the focal adhesion-related tyrosinekinase Pyk2, mitogen-activated protein kinases (MAPK), and phosphoinositol-3kinase. Activation of the MAPK leads to gp120-induced expression of chemokinessuch as monocyte chemoattractant protein-1 and macrophage-inflammatoryprotein-1beta and the proinflammatory cytokine tumor necrosis factor alpha.These responses establish a complex cytokine network, which may enhance orsuppress HIV-1 replication. In addition, dysregulation of macrophage function bygp120/chemokine receptor signaling may contribute to local inflammation andinjury and further recruit additional inflammatory and/or target cells.Targeting these cellular signaling pathways may have benefit in controllinginflammatory sequelae of HIV infection such as in neurological disease.
PMID
12960231
|
Entity
ERK
--
MO000000011
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m26
10
infinite
0
TRANSPATH | MO000000011 |
--
CCR5
--
MO000017281
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2134
10
infinite
0
InterPro | IPR000276 |
TRANSPATH | MO000017281 |
--
MIP-1beta {extracellular}
--
MO000019951
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m4479
10
infinite
0
InterPro | IPR000827 |
TRANSPATH | MO000019951 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
R5 gp120: CD4: CCR5
--
e11
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m11
0
infinite
0
--
X4 gp120: CD4: CXCR4
--
e12
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m12
0
infinite
0
--
MIP-1beta: CCR5
--
e13
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m13
0
infinite
0
--
SDF-1alpha: CXCR4
--
e14
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m14
0
infinite
0
--
R5 gp120: CD4
--
e17
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m17
0
infinite
0
--
X4 gp120: CD4
--
e18
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m18
0
infinite
0
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
p38 [activated}
--
e23
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m25
10
infinite
0
TRANSPATH | MO000000022 |
--
ERK {activated}
--
e24
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m27
10
infinite
0
TRANSPATH | MO000000011 |
--
ZAP-70 {activated}
--
e26
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m29
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000017772 |
--
TFs
--
e27
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
TFs{active}
--
e30
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
csml-variable:Double
m34
0
infinite
0
--
beta-chemokines: CCR5
--
e33
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m36
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
gp120: CD4
--
e5
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
gp120: CD4: GPCR
--
e6
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m15136*m2571*0.1
nodelay
--
0
PMID: 12960231, 10358771 Human immunodeficiency virus type 1 (HIV-1) entry is initiated by binding of the viral envelope (Env) glycoprotein gp120 to CD4 followed by interactions with a G protein-coupled chemokine receptor (GPCR), CCR5 or CXCR4, on the surface of target cells. PMID: 12960231, 10358771 efficient gp120?chemokine interactions typically require that gp120 first binds to CD4 to undergo conformational changes that induce the chemokine receptor binding site.
p10
p10
cso30:i:ME_CytosolicCalciumIonConcentrationElevation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c28 : 1
m12*0.1
nodelay
--
0
PMID: 12960231 CCR5 and CXCR4 elevate [Ca2+]i in a variety of cell types in response to chemokine stimulation. PMID: 12960231 the peak [Ca2+]i elicited by R5 gp120 was nearly twice that elicited by X4 gp120, with higher steady-state levels as well.
p11
p11
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c31 : 1
stoichiometry:c30 : 1
m1787*m6*0.1
nodelay
--
0
PMID: 12960231 In some cell types, gp120 is also known to activate the related cytoskeleton-associated focal adhesion kinase (FAK).
p12
p12
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c33 : 1
stoichiometry:c34 : 1
m19*m1785*0.1
nodelay
--
0
PMID: 12960231, 7544443 Pyk2 is often Ca2+-regulated. PMID: 12960231, 10384144, 9362541 Similar results have been reported in T cells, where Pyk2 and FAK are activated by gp120.
p13
p13
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c39 : 1
stoichiometry:c40 : 1
m11*m22*0.1
nodelay
--
0
PMID: 12960231, 9875330 binding of R5 SIV virions (but not gp120 alone) activated JNK and p38 MAPK as well as ERK through CCR5. PMID: 12960231 Of note, R5 gp120 reliably activated these kinases, and X4 gp120 activation was inconsistent, indicating another difference between the CCR5- and CXCR4-mediated pathways.
p14
p14
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c41 : 1
stoichiometry:c77 : 1
stoichiometry:c42 : 1
m11*m24*0.1
nodelay
--
0
PMID: 12960231, 9875330 binding of R5 SIV virions (but not gp120 alone) activated JNK and p38 MAPK as well as ERK through CCR5. PMID: 12960231 Of note, R5 gp120 reliably activated these kinases, and X4 gp120 activation was inconsistent, indicating another difference between the CCR5- and CXCR4-mediated pathways. PMID: 12960231, 11698270 Upon further investigation, we determined that this was dependent on the p38 MAPK pathway, as a specific p38 MAPK inhibitor (SB202190) blocked their secretion.
p15
p15
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m11*m26*0.1
nodelay
--
0
PMID: 12960231, 9875330 binding of R5 SIV virions (but not gp120 alone) activated JNK and p38 MAPK as well as ERK through CCR5. PMID: 12960231 Of note, R5 gp120 reliably activated these kinases, and X4 gp120 activation was inconsistent, indicating another difference between the CCR5- and CXCR4-mediated pathways.
p16
p16
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c45 : 1
stoichiometry:c46 : 1
m14*m26*0.1
nodelay
--
0
PMID: 12960231, 9658081 Using CD4+/CXCR4+ cell lines, it was reported that binding of X4 HIV-1 gp120 activated extracellular-regulated kinase (ERK), another member of the MAPK family. However, that response was mediated by CD4, as CD4-independent X4 gp120 did not activate ERK through CXCR4, although the natural CXCR4 ligand SDF-1alpha did.
p17
p17
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m12*m26*0.1
nodelay
--
0
PMID: 12960231, 9658081 Using CD4+/CXCR4+ cell lines, it was reported that binding of X4 HIV-1 gp120 activated extracellular-regulated kinase (ERK), another member of the MAPK family. However, that response was mediated by CD4, as CD4-independent X4 gp120 did not activate ERK through CXCR4, although the natural CXCR4 ligand SDF-1alpha did.
p18
p18
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
stoichiometry:c52 : 1
m6*m2113*0.1
nodelay
--
0
PMID: 12960231, 12551992 Similar results showing that soluble and virion-associated gp120 activates PI-3K in macrophages were recently reported.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c55 : 1
stoichiometry:c56 : 1
m6*m93309*0.1
nodelay
--
0
PMID: 12960231, 1548758 We also found that HIV gp120 induced macrophage TNF-alpha production. PMID: 12960231, 2789293, 1918997 It has long been known that gp120 can induce macrophages to secrete tumor necrosis factor alpha (TNF-alpha).
p2
p2
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c8 : 1
stoichiometry:c22 : 1
stoichiometry:c80 : 1
stoichiometry:c12 : 1
m2134*m17*0.1
nodelay
--
0
PMID: 12960231, 10358771 Human immunodeficiency virus type 1 (HIV-1) entry is initiated by binding of the viral envelope (Env) glycoprotein gp120 to CD4 followed by interactions with a G protein-coupled chemokine receptor (GPCR), CCR5 or CXCR4, on the surface of target cells. PMID: 12960231 Here, we will discuss our studies on the intracellular signaling pathways activated in macrophages through CCR5 and CXCR4 in response to envelope proteins from R5 or X4 viruses and contrast them with results in other cell types. PMID: 12960231, 9120386 The beta-chemokines can block virus entry by competing with gp120 for binding to chemokine receptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c57 : 1
m6*0.1
nodelay
--
0
PMID: 12960231, 1548758 We also found that HIV gp120 induced macrophage TNF-alpha production.
p21
p21
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
stoichiometry:c60 : 1
m6*m2529*0.1
nodelay
--
0
PMID: 12960231 Although FAK and ZAP-70 were activated in resting T cells by gp120, it was not clear as to what pathways were specifically responsible for HIV up-regulation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c73 : 1
stoichiometry:c62 : 1
m30*m23*0.1
nodelay
--
0
PMID : 12960231 confirmed pathways(Fig.2.)
p23
p23
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c69 : 1
stoichiometry:c64 : 1
m93710*m25*0.1
nodelay
--
0
PMID: 12960231 We found that macrophages exposed to gp120 produced MCP-1 and MIP-1beta, consistent with other reports. PMID: 12960231, 11698270 Upon further investigation, we determined that this was dependent on the p38 MAPK pathway, as a specific p38 MAPK inhibitor (SB202190) blocked their secretion.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c63 : 1
m25*0.1
nodelay
--
0
PMID: 12960231 We found that macrophages exposed to gp120 produced MCP-1 and MIP-1beta, consistent with other reports. PMID: 12960231, 11698270 Upon further investigation, we determined that this was dependent on the p38 MAPK pathway, as a specific p38 MAPK inhibitor (SB202190) blocked their secretion.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c71 : 1
m25*0.1
nodelay
--
0
PMID: 12960231 We found that macrophages exposed to gp120 produced MCP-1 and MIP-1beta, consistent with other reports. PMID: 12960231, 11698270 Upon further investigation, we determined that this was dependent on the p38 MAPK pathway, as a specific p38 MAPK inhibitor (SB202190) blocked their secretion.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c68 : 1
stoichiometry:c70 : 1
m32*m25*0.1
nodelay
--
0
PMID: 12960231 We found that macrophages exposed to gp120 produced MCP-1 and MIP-1beta, consistent with other reports. PMID: 12960231, 11698270 Upon further investigation, we determined that this was dependent on the p38 MAPK pathway, as a specific p38 MAPK inhibitor (SB202190) blocked their secretion.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c76 : 1
stoichiometry:c82 : 1
m25*m30*0.1
nodelay
--
0
PMID : 12960231 confirmed pathways(Fig.2.)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c83 : 1
stoichiometry:c84 : 1
m27*m30*0.1
nodelay
--
0
PMID : 12960231 confirmed pathways(Fig.2.)
p29
p29
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
stoichiometry:c81 : 1
m2134*m35*0.1
nodelay
--
0
PMID: 12960231, 9120386 The beta-chemokines can block virus entry by competing with gp120 for binding to chemokine receptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m5*m249*0.1
nodelay
--
0
PMID: 12960231, 10358771 Human immunodeficiency virus type 1 (HIV-1) entry is initiated by binding of the viral envelope (Env) glycoprotein gp120 to CD4 followed by interactions with a G protein-coupled chemokine receptor (GPCR), CCR5 or CXCR4, on the surface of target cells.
PMID : 12960231 confirmed pathways(Fig.2.)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c24 : 1
stoichiometry:c11 : 1
m2033*m18*0.1
nodelay
--
0
PMID: 12960231, 10358771 Human immunodeficiency virus type 1 (HIV-1) entry is initiated by binding of the viral envelope (Env) glycoprotein gp120 to CD4 followed by interactions with a G protein-coupled chemokine receptor (GPCR), CCR5 or CXCR4, on the surface of target cells. PMID: 12960231 Here, we will discuss our studies on the intracellular signaling pathways activated in macrophages through CCR5 and CXCR4 in response to envelope proteins from R5 or X4 viruses and contrast them with results in other cell types.
p5
p5
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c17 : 1
m4479*m2134*0.1
nodelay
--
0
PMID: 12960231 macrophage-inflammatory protein-1beta (MIP-1beta; CCL4) and stromal derived factor-1alpha (SDF-1alpha; CXCL12), the natural ligands for CCR5 and CXCR4, respectively. PMIDL 12960231, 10864653 Subsequently, it was reported that HIV-1 and SIV strains with gp120 envelopes that did not elevate [Ca2+]i in macrophages failed to complete replication, and this failure could be complemented by the natural ligand MIP-1?, which converted nonproductive infection to productive infection.
p6
p6
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
stoichiometry:c18 : 1
m2033*m4647*0.1
nodelay
--
0
PMID: 12960231 macrophage-inflammatory protein-1beta (MIP-1beta; CCL4) and stromal derived factor-1alpha (SDF-1alpha; CXCL12), the natural ligands for CCR5 and CXCR4, respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c9 : 1
stoichiometry:c21 : 1
m15*m2571*0.1
nodelay
--
0
PMID: 12960231 Here, we will discuss our studies on the intracellular signaling pathways activated in macrophages through CCR5 and CXCR4 in response to envelope proteins from R5 or X4 viruses and contrast them with results in other cell types. PMID: 12960231, 10358771 efficient gp120?chemokine interactions typically require that gp120 first binds to CD4 to undergo conformational changes that induce the chemokine receptor binding site.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c23 : 1
m2571*m16*0.1
nodelay
--
0
PMID: 12960231 Here, we will discuss our studies on the intracellular signaling pathways activated in macrophages through CCR5 and CXCR4 in response to envelope proteins from R5 or X4 viruses and contrast them with results in other cell types. PMID: 12960231, 10358771 efficient gp120?chemokine interactions typically require that gp120 first binds to CD4 to undergo conformational changes that induce the chemokine receptor binding site.
p9
p9
cso30:i:ME_CytosolicCalciumIonConcentrationElevation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c27 : 1
m11*0.1
nodelay
--
0
PMID: 12960231 CCR5 and CXCR4 elevate [Ca2+]i in a variety of cell types in response to chemokine stimulation. PMID: 12960231 the peak [Ca2+]i elicited by R5 gp120 was nearly twice that elicited by X4 gp120, with higher steady-state levels as well.
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--